Back to ALPMYView Full Landscape
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
2
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
15 competitors in Type 2 Diabetes Mellitus
LLYInsulin Peglispro
Phase 3LLYDulaglutide
Phase 3AZNexenatide twice daily
Phase 3LLYInsulin Lispro
Phase 3LLYInsulin Degludec
Phase 3Drug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Regulatory Approvals
EMA4/3/2001
Trazec
Nateglinide is indicated for combination therapy with metformin in type 2 diabetic patients inadequately controlled despite a maximally tolerated dose of metformin alone.
View on EMAEMA4/3/2001
Starlix
Nateglinide is indicated for combination therapy with metformin in type-2 diabetic patients inadequately controlled despite a maximally tolerated dose of metformin alone.
View on EMADrug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts